Xcl2

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 27.02.2022

Dieser Artikel auf Deutsch

Synonym(s)

lymphotactin-2; SCM-1b; SCYC2

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Chemokines, a subgroup of cytokines, are small (size between 8 and 10 kDa), chemotactically active proteins (signal proteins). They are common in all vertebrates, some virus types and bacteria. In humans, about 50 chemokines are currently known. A strongly conserved structural feature of all chemokines is a fixed group of cysteine residues that is stabilized by 1 or 2 disulfide bridges. This key structural position in the molecule is responsible for its fixed 3-dimensional structure.

In the CC chemokines, the cysteines follow each other directly (see figure), in the CXC chemokines they are separated (CC = acronym for cysteine-cysteine) by 1, in the CXXXC chemokines by 3 other amino acids. Chemokines are produced and secreted by a variety of immune cells, but also by parenchymatous cells. They transmit their signals by binding to chemokine receptors via G-proteins. Some chemokines have a pro-inflammatory effect, others have a regulatory effect on the formation, homeostasis or proliferation of tissues.

Human XCL2, also known as lymphotactin2, SCYC2 or SCM1beta is a small, 10 kDa glycoprotein of the C chemokine family. XCL1/lymphotactin-1 is a closely related chemokine of the same family that differs from XCL2 only in 2 amino acids, but appears to be subject to separate regulation.

General informationThis section has been translated automatically.

XCL2 and XCL1/lymphotactin-1 bind and activate the G protein-coupled chemokine receptor XCR1 (the coding gene is located on chromosome 1 in humans). This receptor is expressed on dendritic cells and on T and B lymphocytes. Binding of XCL2 to the receptor XCR1 leads to chemotactic migration of these cells.

Also detected is the XCR1 receptor on ovarian cancer (EOC) cells, hepatocellular carcinoma cells, and bronchial carcinoma cells. Thus, XCL1 and XCL2 (among other cytokines) may play a role in the expansion of these tumor cells. In lung carcinoma, the expressivity of XCL2 is correlated with malignancy progression.

XCL2, but not XCL1, is increased in expression by macrophages after activation by an antigen of Mycobacterium tuberculosis (Wag31). Activation of T cells results in a marked increase in chemokines XCL1 and XCL2 in CD8+ T cells. Activated CD4+ T cells express increased levels of XCL2 but not XCL1. These results indicate that both chemokines are regulated independently.

LiteratureThis section has been translated automatically.

  1. Cao W et al (2008) Mycobacterium tuberculosis antigen Wag31 induces expression of C-chemokines XCL2 in macrophages. Curr microbiol 57:189-194.
  2. Fox JC et al (2015) Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. Cytokines 71:302-311.
  3. Kim M et al (2012) The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation. Mol Cancer Res 10:1419-1429.
  4. Xuan W et al (2015) The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol 97:61-69.
  5. Zhou B et al (2016) Expression of chemokines XCL2 and CX3CL1 in lung cancer. Med Sci Monit 22:1560-1565.

Authors

Last updated on: 27.02.2022